| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 127,087 | 134,483 | 362,176 | 267,677 | | Cost of Revenue | 49,466 | 119,543 | 288,421 | 129,892 | | | Gross Profit | 77,621 | 14,940 | 73,755 | 137,785 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 69,656 | (3,461) | 7,322 | 85,749 | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 7,880 | 7,629 | 7,660 | 7,479 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 85 | 10,772 | 58,773 | 44,557 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 294 | (117) | 461 | (118) | | Earnings Before Interest And Taxes | 379 | 10,655 | 59,234 | 44,439 | | Interest Expense | 5,298 | 4,112 | 4,893 | 8,430 | | Income Before Tax | (4,919) | 6,543 | 54,341 | 36,009 | | Income Tax Expense | (3,206) | 3,056 | 20,218 | 13,703 | | Minority Interest | 169 | (24) |
-
|
-
| | | | Net Income From Continuing Ops | (2,003) | 4,965 | 31,688 | 21,889 | | | Non-recurring Events | | Discontinued Operations | (16) | (23) | (19) | (146) | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (1,874) | 4,942 | 31,669 | 21,743 | | Preferred Stock And Other Adjustments |
-
| 66 | (66) |
-
| | | Net Income Applicable To Common Shares | ($1,874) | $5,008 | $31,603 | $21,743 |
|
1.23% Nasdaq 0.00%
Income Statement
